Welcome to our dedicated page for Mountain Vy Md news (Ticker: MVMDF), a resource for investors and traders seeking the latest updates and insights on Mountain Vy Md stock.
Mountain Vy Md Inc (MVMDF) delivers innovative solutions across healthcare and diversified industries. This news hub provides investors with essential updates about corporate developments, strategic decisions, and market positioning.
Comprehensive Coverage: Access all official press releases alongside third-party analysis of financial results, partnership announcements, and operational milestones. Our curated feed eliminates the need to monitor multiple sources.
Key Focus Areas: Track updates on leadership changes, technology implementations, regulatory compliance, and growth initiatives. Content spans quarterly earnings disclosures, merger activity, and industry trend responses.
Staying Informed: Bookmark this page for streamlined access to MVMDF's evolving story. Check regularly for objective reporting that supports informed investment decisions.
Mountain Valley MD (OTCQB:MVMDF) provided a comprehensive business update across its three core technology divisions. The company's Quicksome™ nutraceutical division reported progress with its U.S.-based GMP manufacturer, including USD $193,000 in Q2 2025 sales through licensee Circadian Wellness Corp.
In agriculture, the company's Agrarius technology demonstrated significant yield improvements in field trials: 14.8% increase in corn yield, 10% in sugarcane, and 18.49% in potatoes. The company expanded trials across multiple crops and secured regulatory approvals in several Latin American countries.
The Soluvec™ 1% division reported production of 200 tonnes of coated fish feed in Bangladesh, though royalty revenues were below expectations due to cyclone impact. MVMD is pursuing patent protection in 12 additional markets and plans expansion into Latin America.
Mountain Valley MD Holdings (OTCQB: MVMDF) has announced changes to its Board of Directors. The company appointed David Batchelor, a seasoned organizational strategist with over 25 years of experience in business transformation and performance improvement.
Batchelor brings extensive experience working with global leaders like Cisco, Coca-Cola, IBM, Merck, Bayer, and Johnson & Johnson. He holds a Master's degree in Distributed Learning and has held faculty positions at Schulich Executive Education Centre and Royal Roads University.
The company also announced the resignations of directors Kevin Puloski and Nancy Richardson. These board changes align with MVMD's focus on growth, commercialization, and disciplined capital deployment.
Mountain Valley MD Holdings (MVMD) provided a year-end update on its commercialization progress across three core areas: Nutraceuticals, Agriculture, and Husbandry Animals/Aquatic Species. In Nutraceuticals, the company advanced its Quicksome™ technology through partnerships and product developments, including an OUD formulation and testosterone products. The agriculture division expanded its Agrarius technology presence, securing registrations in multiple countries and implementing a Performance Guarantee Program. In the Husbandry/Aquatic segment, their Soluvec™ 1% product achieved initial sales of 100 tonnes of coated fish feed in Bangladesh, with manufacturing resuming in November 2024 after cyclone-related disruptions.
Mountain Valley MD Holdings Inc. (MVMD) provided a business update on its three core lines: Nutraceuticals, Agriculture, and Husbandry Animals/Aquatic Species. Key developments include:
1. Nutraceuticals: Completed setup for Quicksome™ technology production. Launched Eons Deeper Sleep product with Circadian Wellness. Internal testing showed improved sleep metrics.
2. Agriculture: Acquired exclusive license for Agrarius agricultural technology in the Americas and Caribbean. Obtained product registration in EU, 44 US states, Canada, and Brazil. Launched Performance Guarantee Program for North American farmers.
3. Husbandry/Aquatic: Developed Soluvec™ 1% (solubilized Ivermectin) for animal applications. Licensed to a partner in Bangladesh for fish feed coating, with shipments planned for Q3 2024.